Samsung DIO Tablets 80/12.5 Milligrams
Valsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Samsung Pharm Co., Ltd.
MFDS item code 201904432 · Approved 2019.06.28
This product's status changed to Expired on 2024.06.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension who do not have sufficient blood pressure control with monotherapy.
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is intended for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is needed in patients with mild ~ moderate renal impairment (creatinine clearance 30 mL/min or greater). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not exceed 80 mg of valsartan per day.
This medicine can cause serious damage to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. It should not be administered to patients with hypersensitivity to this medication or those with severe liver or kidney disorders. Caution is required when using this medication in patients with electrolyte imbalances, poor kidney function, elderly patients, and patients with heart conditions. Dizziness or drowsiness may occur while taking this medication, so caution should be exercised while driving or operating machinery. It may pose risks when used with potassium supplements or potassium-containing medications, so consultation with a physician is necessary. This medication can cause sensitivity to sunlight, so it is recommended to avoid sun exposure and take protective measures. If unusual symptoms such as skin rashes or shortness of breath occur during treatment, it is important to notify a doctor immediately. Regular checks for kidney and liver function are essential, and electrolyte levels should also be monitored regularly. Women who are pregnant or breastfeeding should not use this medication and should consult a physician if necessary. Safety and efficacy in children have not been established, so it should not be used in this population. In case of overdose, symptoms such as hypotension, arrhythmias, and electrolyte abnormalities may occur, requiring emergency treatment. This medication should be stored in a sealed container, protected from moisture, and kept out of reach of children, preferably in the original container.
Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, dyspnea, erectile dysfunction, enteritis, hyperhidrosis, sensory impairment, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myositis, nausea, nasal congestion, nasal hemorrhage, throat pain, otitis media, limb pain, abnormal sensation, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, symptoms resembling anaphylaxis, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, exacerbation of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, reduced hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, vesicular dermatitis, joint pain, weakness, low back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory infection, elevated blood lipids, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, decreased appetite, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, depression, abnormal sensation, visual impairment, leukopenia, bone marrow dysfunction, acute respiratory distress syndrome, pneumonia, pulmonary edema, acute renal failure, renal dysfunction, erythema multiforme, fever, acute angle-closure glaucoma, vomiting, drowsiness, hypovolemia, arrhythmia, muscle stiffness
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container to protect it from air and moisture, and it is advisable to maintain the temperature below 30 degrees Celsius. Proper storage will help retain the medication's effectiveness for a longer period.
Pink oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Samsung Pharm Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Hydrochlorothiazide
Prescription medication · Combination
Sandoz Korea Co., Ltd.
Valsartan · Hydrochlorothiazide
Prescription medication · Combination
Sandoz Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Anguk Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.